Karaciğer Tümörlerinde Histopatolojik Değerlendirme: Morfolojik Özellikler, Tanısal Yaklaşımlar ve Güncel Uygulamalar

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2024;74(3):229-263.

Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA; WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182-188.

Choi JH, Thung SN. Advances in histological and molecular classification of hepatocellular carcinoma. Biomedicines. 2023;11(9):2582.

Brunt EM. Histopathologic features of hepatocellular carcinoma. Clinical Liver Disease. 2012;1(6):194-199.

Torbenson M. Fibrolamellar carcinoma: 2012 update. Scientifica. 2012;2012:743790.

Chung T, Park YN. Up-to-date pathologic classification and molecular characteristics of intrahepatic cholangiocarcinoma. Frontiers in Medicine. 2022;9:857140.

Guedj N, Paradis V. Pathology of cholangiocarcinomas. Current Oncology. 2022;30(1):30.

Sas Z, Cendrowicz E, Weinhäuser I, Rygiel TP. Tumor microenvironment of hepatocellular carcinoma: challenges and opportunities for new treatment options. Cancers. 2022;14(7):1721.

Cadamuro M, Brivio S, Mertens J, Vismara M, Moncsek A, Milani C, et al. Dissecting the functions of cancer-associated fibroblasts in hepatocellular carcinoma. Hepatoma Research. 2023;9:47.

Di Tommaso L, Franchi G, Park YN, Fiamengo B, Destro A, Morenghi E, et al. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology. 2007;45(3):725-734.

Zhang N, Yang X, Piao M, Xun Z, Wang Y, Ning C, et al. Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma. Biomarker Research. 2024;12:26.

Erstad DJ, Tanabe KK. Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Annals of Surgical Oncology. 2019;26(5):1474-1493.

Cigliano A, Pilo MG, Szydlowska M, Ribback S, Dombrowski F, Calvisi DF. Preclinical models of hepatocellular carcinoma: a comprehensive review. Cancers (Basel). 2024;16(4):742.

Qureshi AA, Sarker D, Nuciforo S. Tumor organoids for primary liver cancers: a systematic review. JHEP Reports. 2024;6(2):100976.